review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | B Richardson | |
P M Moore | |||
P2860 | cites work | Allergic granulomatosis, allergic angiitis, and periarteritis nodosa | Q24682741 |
Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? | Q27473540 | ||
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
Nomenclature of systemic vasculitides. Proposal of an international consensus conference | Q29616304 | ||
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis | Q29619713 | ||
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis | Q29619714 | ||
Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55 | Q33189486 | ||
Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome | Q33391117 | ||
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity | Q33479779 | ||
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. | Q33561938 | ||
Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases | Q33566332 | ||
Development of a functional scoring system for rheumatoid arthritis patients with cervical myelopathy | Q33579517 | ||
Lupus-related myelopathy: report of three cases and review of the literature | Q33591479 | ||
Cryptococcal meningitis | Q33621390 | ||
Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic | Q34061539 | ||
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa | Q68094282 | ||
Immunopathologic study of sural nerves in rheumatoid arthritis | Q68641821 | ||
Necrotizing angiitis associated with drug abuse | Q68748157 | ||
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome | Q68757900 | ||
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases | Q69350471 | ||
Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease | Q69425766 | ||
The peripheral neuropathy of necrotizing arteritis: a clinicopathological study | Q69831408 | ||
Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients | Q69890910 | ||
Churg-Strauss syndrome (allergic granulomatous angiitis). Neuro-ophthalmologic manifestations | Q70156586 | ||
Autoantibodies in vasculitis: current perspectives | Q70489895 | ||
Is temporal artery biopsy prudent? | Q70654142 | ||
Ocular complications of Wegener's granulomatosis | Q70989120 | ||
Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients | Q71018624 | ||
Rheumatoid arthritis | Q71046923 | ||
Pathogenetic mechanism and prevalence of the stable atlantoaxial subluxation in rheumatoid arthritis | Q71304165 | ||
Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes | Q71614421 | ||
Serial angiography in isolated angiitis of the central nervous system | Q72071736 | ||
Vascular endothelium as a major participant in T-lymphocyte immunity | Q72115606 | ||
Rheumatoid involvement of the cervical spine. An overview | Q72522427 | ||
Leukocyte involvement in vasomotor reactivity of the cerebral vasculature | Q72841721 | ||
Sjögren's syndrome presenting as ischemic stroke | Q72841793 | ||
Chorea in a child with Churg-Strauss syndrome | Q72859090 | ||
Central nervous system vasculitis in cytomegalovirus infection | Q72906558 | ||
Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients | Q72907786 | ||
PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS | Q78284889 | ||
Noninfectious granulomatous angiitis with a predilection for the nervous system | Q79201588 | ||
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). | Q34226979 | ||
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis | Q34226990 | ||
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis | Q34227003 | ||
Endothelium-dependent vascular responses. Mediators and mechanisms | Q34578188 | ||
Neurologic disease in biopsy-proven giant cell (temporal) arteritis | Q34687501 | ||
Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited | Q35596647 | ||
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 | Q35612515 | ||
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review | Q35996951 | ||
The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon | Q36263995 | ||
STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS. II. PATHOGENETIC AND PHARMACODYNAMIC STUDIES | Q36266378 | ||
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells | Q36349437 | ||
Self-regulation of procoagulant events on the endothelial cell surface | Q36350976 | ||
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome | Q36353173 | ||
Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation | Q36476893 | ||
Wegener's granulomatosis presenting as a primary seizure disorder with brain lesions demonstrated by magnetic resonance imaging | Q36774748 | ||
Temporal arteritis with low erythrocyte sedimentation rate: A review of five cases | Q36807548 | ||
Rheumatoid neuropathy: a histological and electrophysiological study | Q37071438 | ||
Churg-Strauss vasculitis presenting with severe visual loss due to bilateral sequential optic neuropathy | Q37299818 | ||
Lymphocyte interacting adhesion molecules on brain microvascular cells | Q37608218 | ||
Leukocyte adhesion to endothelium in inflammation | Q37938615 | ||
Role of cytokines and platelet-activating factor in microvascular immune injury. | Q38619185 | ||
Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases | Q39156472 | ||
Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis | Q39253737 | ||
Immunosuppressive and corticosteroid therapy of polyarteritis nodosa | Q39291060 | ||
Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium | Q39477525 | ||
The clinical neuro-ophthalmologic spectrum of temporal arteritis | Q39543898 | ||
Vasculitis associated with malignancy. Experience with 13 patients and literature review. | Q39652337 | ||
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage | Q40152525 | ||
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. | Q40170990 | ||
Paraneoplastic vasculitis of nerve: A remote effect of cancer | Q40242773 | ||
Neoplastic angioendotheliosis: ultrastructural study and review of the literature | Q40354721 | ||
Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction | Q40371891 | ||
Central nervous system vasculitis secondary to infections, toxins, and neoplasms | Q40501823 | ||
The emerging concept of vascular remodeling | Q40740827 | ||
Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients | Q40784645 | ||
Nervous system involvement in systemic lupus erythematosus, Sjögren syndrome and scleroderma | Q40788054 | ||
Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience | Q40838917 | ||
Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases | Q40849058 | ||
'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis | Q40854254 | ||
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects | Q40868442 | ||
Drug related vasculitis. Clinicopathologic correlations in 30 patients | Q40868722 | ||
Pathogenesis of giant cell arteritis | Q40914456 | ||
Mechanisms of sickness-induced decreases in food-motivated behavior | Q40982338 | ||
Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action. | Q41207017 | ||
Clinical features, pathogenesis, and treatment of Sjögren's syndrome | Q41241410 | ||
Herpes zoster maxillaris with delayed occipital infarction | Q41353935 | ||
Biologic agents for treating rheumatoid arthritis. Concepts and progress | Q41398093 | ||
Neuropsychiatric systemic lupus erythematosus. Stress, stroke, and seizures | Q41590473 | ||
Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases | Q43721970 | ||
Biopsy-proven cerebral vasculitis associated with cocaine abuse | Q43796729 | ||
Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients | Q43802277 | ||
Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome | Q44260485 | ||
Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study | Q44326336 | ||
Microscopic polyarteritis: presentation, pathology and prognosis | Q44598128 | ||
Diagnosis and management of isolated angiitis of the central nervous system | Q44610051 | ||
Wegener Granulomatosis: An Analysis of 158 Patients | Q45267316 | ||
A neuropathological study of a case of lupus erythematosus with chorea | Q45289613 | ||
Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium | Q45865181 | ||
Prostacyclin synthesis induced in vascular cells by interleukin-1. | Q46155075 | ||
A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus. | Q48116322 | ||
Intraventricular and subarachnoid hemorrhage resulting from necrotizing vasculitis of the choroid plexus in a patient with Churg-Strauss syndrome | Q48328112 | ||
Inducible expression of H-2 and Ia antigens on brain cells | Q48633246 | ||
Vasculitic neuropathy. A clinical and pathological study | Q48652489 | ||
Cerebral arteritis and bacterial meningitis | Q48672928 | ||
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches | Q48719794 | ||
Primary Sjögren's syndrome presenting as progressive parkinsonian syndrome | Q48822600 | ||
Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen | Q49021098 | ||
Granulomatous Angiitis of the Central Nervous System | Q49132354 | ||
Hearing loss in the Sjögren syndrome. | Q50509997 | ||
CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF PERIARTERITIS NODOSA. | Q51256462 | ||
Neurological manifestations of systemic lupus erythematosus: a prospective study | Q52048236 | ||
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study | Q52877882 | ||
Long-term follow-up study of periarteritis nodosa. | Q53794085 | ||
Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa | Q57279770 | ||
Cerebral angiographic changes in the drug abuse patient | Q67233240 | ||
Cervical radiculopathy: a rare symptom of giant cell arteritis | Q67263934 | ||
Cell activation and the role of cell-mediated immunity in vasculitis | Q67881721 | ||
Activated, cytotoxic lymphocytes in systemic vasculitis | Q67904350 | ||
Clinical analysis of isolated angiitis of the central nervous system. A report of 11 cases | Q68061064 | ||
Systemic lupus erythematosus presenting with neurological disorders | Q68080217 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | connective tissue | Q25615 |
P304 | page(s) | 10-22 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Neurology of the vasculitides and connective tissue diseases | |
P478 | volume | 65 |
Q45233964 | A fatal demyelinating illness in a young woman 10 weeks post partum. |
Q36490337 | Acute manifestations of autoimmune connective tissue diseases |
Q30438726 | An update on the classification and treatment of vasculitic neuropathy |
Q35236240 | Brain biopsy in neurologic decline of unknown etiology |
Q33204474 | Cerebral vasculitis |
Q48338331 | Convergence paralysis as a manifestation of polyarteritis nodosa. |
Q35692994 | Cranial neuralgias and headaches associated with cranial vascular disorders |
Q53648041 | Diffusion-weighted MR findings in isolated angiitis of the central nervous system (IACNS) |
Q40042233 | Epidemiology of Peripheral Neuropathy: An Indian Perspective |
Q38788562 | Evaluating the safety of β-interferons in MS: A series of nested case-control studies |
Q53250209 | Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. |
Q37602031 | Immunomodulatory therapies in neurologic critical care |
Q35550816 | Involvement of the peripheral nervous system in primary Sjögren's syndrome |
Q39880959 | Isolated angiitis of the CNS and bacterial endocarditis: similarities and differences |
Q53105387 | Nerve biopsy in Indian patients with mononeuropathy multiplex of undetermined etiology. |
Q31953061 | Neurology and the kidney |
Q24673115 | Neurology and the skin |
Q38215698 | Neurology of rheumatologic disorders |
Q39721039 | Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background |
Q39667841 | Posterior encephalopathy with vasospasm: MRI and angiography |
Q24816747 | Primary angiitis of the central nervous system presenting with subacute and fatal course of disease: a case report |
Q80374363 | Primary central nervous system angiitis in a 10-year-old girl |
Q36894419 | Rapidly progressive dementia |
Q42034203 | Rapidly progressive dementia |
Q33846569 | Role of magnetic resonance imaging in the diagnosis of primary central nervous system angiitis |
Q21284858 | The destructive capacity of drug abuse: an overview exploring the harmful potential of drug abuse both to the individual and to society |
Q34659256 | Vascular dementia: a review of recent evidence for prevention and treatment |
Q81596252 | [Cerebral angiitis caused by periarteritis nodosa] |
Q88430482 | [Clinical aspects and diagnostics of cerebral vasculitis] |
Q75448266 | [Diagnosis and differential cerebral vasculitis diagnosis] |
Q82647018 | [Vasculitis of the nervous system in infectious diseases] |
Search more.